APRE
Price
$1.75
Change
-$0.06 (-3.31%)
Updated
Jun 6 closing price
Capitalization
9.68M
CABA
Price
$2.48
Change
+$0.30 (+13.76%)
Updated
Jun 6 closing price
Capitalization
125.84M
61 days until earnings call
Interact to see
Advertisement

APRE vs CABA

Header iconAPRE vs CABA Comparison
Open Charts APRE vs CABABanner chart's image
Aprea Therapeutics
Price$1.75
Change-$0.06 (-3.31%)
Volume$24.17K
Capitalization9.68M
Cabaletta Bio
Price$2.48
Change+$0.30 (+13.76%)
Volume$2.32M
Capitalization125.84M
APRE vs CABA Comparison Chart
Loading...
APRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APRE vs. CABA commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APRE is a Buy and CABA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (APRE: $1.75 vs. CABA: $2.48)
Brand notoriety: APRE and CABA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APRE: 80% vs. CABA: 145%
Market capitalization -- APRE: $9.68M vs. CABA: $125.84M
APRE [@Biotechnology] is valued at $9.68M. CABA’s [@Biotechnology] market capitalization is $125.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APRE’s FA Score shows that 2 FA rating(s) are green whileCABA’s FA Score has 1 green FA rating(s).

  • APRE’s FA Score: 2 green, 3 red.
  • CABA’s FA Score: 1 green, 4 red.
According to our system of comparison, APRE is a better buy in the long-term than CABA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APRE’s TA Score shows that 6 TA indicator(s) are bullish while CABA’s TA Score has 5 bullish TA indicator(s).

  • APRE’s TA Score: 6 bullish, 2 bearish.
  • CABA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, APRE is a better buy in the short-term than CABA.

Price Growth

APRE (@Biotechnology) experienced а +0.57% price change this week, while CABA (@Biotechnology) price change was +32.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

APRE is expected to report earnings on Mar 25, 2025.

CABA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CABA($126M) has a higher market cap than APRE($9.68M). CABA YTD gains are higher at: 9.251 vs. APRE (-46.809). APRE has higher annual earnings (EBITDA): -14.75M vs. CABA (-112.92M). CABA has more cash in the bank: 183M vs. APRE (26.2M). APRE has less debt than CABA: APRE (0) vs CABA (15.2M). APRE (0) and CABA (0) have equivalent revenues.
APRECABAAPRE / CABA
Capitalization9.68M126M8%
EBITDA-14.75M-112.92M13%
Gain YTD-46.8099.251-506%
P/E RatioN/AN/A-
Revenue00-
Total Cash26.2M183M14%
Total Debt015.2M-
TECHNICAL ANALYSIS
Technical Analysis
APRECABA
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
90%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
88%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 11 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
APRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KRKNF2.080.26
+14.29%
Kraken Robotics Inc.
JBAXY12.780.11
+0.89%
Julius Baer Group Ltd.
NONOF73.420.32
+0.44%
Novo-Nordisk A/S
JMPLY45.23-0.39
-0.84%
Johnson Matthey plc
SCMWY68.94-0.60
-0.87%
Swisscom AG

CABA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CABA has been loosely correlated with KYTX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CABA jumps, then KYTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CABA
1D Price
Change %
CABA100%
+13.76%
KYTX - CABA
46%
Loosely correlated
+15.31%
IPSC - CABA
44%
Loosely correlated
+9.47%
IMNM - CABA
43%
Loosely correlated
+0.11%
PRME - CABA
43%
Loosely correlated
+24.26%
ARCT - CABA
42%
Loosely correlated
+7.39%
More